Prognostic Value of C-Reactive Protein in SARS-CoV-2 Infection: A Simplified Biomarker of COVID-19 Severity in Northern Ethiopia

References

• Lemos S, Solari PN. John Hopkins got incidence rate wrong: a close look at John Hopkins University’s web-based interactive dashboard for real-time tracking of COVID-19. Johns Hopkins Coronavirus Resource Center (jhu.edu); 2023.
   Google Scholar
• Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease. N Engl J Med. 2019;2019:1708–1720.
   Google Scholar
• de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet. 2003;362(9380):316–322. doi:10.1016/S0140-6736(03)13976-1
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052–2059. doi:10.1001/jama.2020.6775
   PubMed Web of Science ®Google Scholar
• Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for disease control and prevention. JAMA. 2020;323(13):1239–1242. doi:10.1001/jama.2020.2648
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3
   PubMed Web of Science ®Google Scholar
• Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–481. doi:10.1016/S2213-2600(20)30079-5
   PubMed Web of Science ®Google Scholar
• Abraha HE, Gessesse Z, Gebrecherkos T, et al. Clinical features and risk factors associated with morbidity and mortality among patients with COVID-19 in northern Ethiopia. Int J Infect Dis. 2021;105:776–783. doi:10.1016/j.ijid.2021.03.037
   PubMed Web of Science ®Google Scholar
• Nachega JB, Ishoso DK, Otokoye JO, et al. Clinical characteristics and outcomes of patients hospitalized for COVID-19 in Africa: early insights from the Democratic Republic of the Congo. Am J Trop Med Hyg. 2020;103(6):2419. doi:10.4269/ajtmh.20-1240
   PubMed Web of Science ®Google Scholar
• Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368(6490):473–474. doi:10.1126/science.abb8925
   PubMed Web of Science ®Google Scholar
• Tay M, Poh C, Nia LRX, MacAry PA, Ng LFP. The trinity of 467 COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20:363–374. doi:10.1038/s41577-020-0311-8
   PubMed Web of Science ®Google Scholar
• Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Investig. 2020;130(5):2620–2629. doi:10.1172/JCI137244
   PubMed Web of Science ®Google Scholar
• Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–422. doi:10.1016/S2213-2600(20)30076-X
   PubMed Web of Science ®Google Scholar
• Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762–768. doi:10.1093/cid/ciaa248
   PubMed Web of Science ®Google Scholar
• Lucas C, Wong P, Klein J, et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020;584(7821):463–469. doi:10.1038/s41586-020-2588-y
   PubMed Web of Science ®Google Scholar
• Mathew D, Giles JR, Baxter AE, et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science. 2020;369(6508):eabc8511. doi:10.1126/science.abc8511
   PubMed Web of Science ®Google Scholar
• D’Alessandro A, Thomas T, Dzieciatkowska M, et al. Serum proteomics in COVID-19 patients: altered coagulation and complement status as a function of IL-6 level. J. Proteome Res. 2020;19(11):4417–4427. doi:10.1021/acs.jproteome.0c00365
   PubMed Web of Science ®Google Scholar
• Jose RJ, Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir Med. 2020;8(6):e46–e47. doi:10.1016/S2213-2600(20)30216-2
   PubMed Web of Science ®Google Scholar
• Giamarellos-Bourboulis EJ, Netea MG, Rovina N, et al. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe. 2020;27(6):992–1000. doi:10.1016/j.chom.2020.04.009
   PubMed Web of Science ®Google Scholar
• Lee DW, Gardner R, Porter DL, et al. Current concepts in the diagnosis and management of cytokine release syndrome. Am J Hematol. 2014;124(2):188–195.
   Google Scholar
• Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Investig. 2003;111(12):1805–1812. doi:10.1172/JCI200318921
   PubMed Web of Science ®Google Scholar
• Liu F, Li L, Xu M, et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 2020;127:104370. doi:10.1016/j.jcv.2020.104370
   PubMed Web of Science ®Google Scholar
• Herold T, Jurinovic V, Arnreich C, et al. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. J Allergy Clin Immunol. 2020;146(1):128–136. doi:10.1016/j.jaci.2020.05.008
   PubMed Web of Science ®Google Scholar
• Han H, Ma Q, Li C, et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect. 2020;9(1):1123–1130. doi:10.1080/22221751.2020.1770129
   PubMed Web of Science ®Google Scholar
• Bergantini L, Bargagli E, d’Alessandro M. d’Alessandro M, et al. Prognostic bioindicators in severe COVID-19 patients. Cytokine. 2021;141:155455. doi:10.1016/j.cyto.2021.155455
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng KI, Liu S, Yan Z, Xu C, Plasma QZ. CRP level is positively associated with the severity of COVID-19. Ann Clin Microbiol Antimicrob. 2020;19(1):1–7. doi:10.1186/s12941-020-00362-2
   PubMed Web of Science ®Google Scholar
• Tan C, Huang Y, Shi F, et al. C‐reactive protein correlates with computed tomographic findings and predicts severe COVID‐19 early. J Med Virol. 2020;92(7):856–862. doi:10.1002/jmv.25871
   PubMed Web of Science ®Google Scholar
• Bhargava A, Fukushima EA, Levine M, et al. Predictors for severe COVID-19 infection. Clin Infect Dis. 2020;71(8):1962–1968. doi:10.1093/cid/ciaa674
   PubMed Web of Science ®Google Scholar
• Wang G, Wu C, Zhang Q, et al. C-reactive protein level may predict the risk of COVID-19 aggravation. Paper presented at Open forum Infectious diseases; 2020.
   Google Scholar
• Huyut MT, Huyut Z, Ilkbahar F, Mertoğlu C. What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality? Int Immunopharmacol. 2022;105:108542. doi:10.1016/j.intimp.2022.108542
   PubMed Web of Science ®Google Scholar
• Huyut MT, Ilkbahar F. The effectiveness of blood routine parameters and some biomarkers as a potential diagnostic tool in the diagnosis and prognosis of Covid-19 disease. Int Immunopharmacol. 2021;98:107838. doi:10.1016/j.intimp.2021.107838
   PubMed Web of Science ®Google Scholar
• Mertoglu C, Huyut MT, Arslan Y, Ceylan Y, Coban TA. How do routine laboratory tests change in coronavirus disease 2019? Scand J Clin Lab Invest. 2021;81(1):24–33. doi:10.1080/00365513.2020.1855470
   PubMed Web of Science ®Google Scholar
• Challa F, Gelibo T, Getahun T, et al. Distribution and determinants of serum high-sensitivity C-reactive protein in Ethiopian population. Clin Chim Acta. 2021;517:99–107. doi:10.1016/j.cca.2021.02.013
   PubMed Web of Science ®Google Scholar
• International Severe Acute Respiratory and Emerging Infection Consortium, COVID- 19 CRF ISARIC. Clinical data collection – the COVID-19 Case Report Forms (CRFs); 2020. Available from: https://isarictghnorg/COVID-19-CRF/. Accessed May 5, 2023.
   Google Scholar
• Haran G, Cohen R, Bar LK, Barenholz Y. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochimica et biophysica acta. 1993;1151(2):201–215. doi:10.1016/0005-2736(93)90105-9
   PubMed Web of Science ®Google Scholar
• Abayomi A, Odukoya O, Osibogun A, et al. Presenting symptoms and predictors of poor outcomes among 2184 patients with COVID-19 in Lagos State, Nigeria. Int J Infect Dis. 2021;102:226–232. doi:10.1016/j.ijid.2020.10.024
   PubMed Web of Science ®Google Scholar
• Parker A, Koegelenberg CF, Moolla MS, et al. High HIV prevalence in an early cohort of hospital admissions with COVID-19 in Cape Town, South Africa. SAMJ. 2020;110(9):1. doi:10.7196/SAMJ.2020.v110i10.15067
   Google Scholar
• Fachri M, Hatta M, Widowati E, et al. Correlations between comorbidities, chest x-ray findings, and C-Reactive protein level in patients with COVID-19. Ann Med Surg. 2022;77:103553. doi:10.1016/j.amsu.2022.103553
   PubMed Web of Science ®Google Scholar
• Stringer D, Braude P, Myint PK, et al. The role of C-reactive protein as a prognostic marker in COVID-19. Int J Epidemiol. 2021;50(2):420–429. doi:10.1093/ije/dyab012
   PubMed Web of Science ®Google Scholar
• Sadeghi-Haddad-Zavareh M, Bayani M, Shokri M, et al. C-reactive protein as a prognostic indicator in COVID-19 patients. Interdiscip Perspect Infect Dis. 2021;2021:1–5. doi:10.1155/2021/5557582
   Google Scholar
• Xu X, Han M, Li T, et al. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci. 2020;117(20):10970–10975. doi:10.1073/pnas.2005615117
   PubMed Web of Science ®Google Scholar
• Huyut MT, Velichko A. Diagnosis and Prognosis of COVID-19 disease using routine blood values and LogNNet neural network. Sensors. 2022;22(13):4820. doi:10.3390/s22134820
   PubMed Web of Science ®Google Scholar
• Huyut M. Automatic detection of severely and mildly infected COVID-19 patients with supervised machine learning models. IRBM. 2023;44(1):100725. doi:10.1016/j.irbm.2022.05.006
   Web of Science ®Google Scholar